Pulmonx Corporation (LUNG) Reports Q4 Loss, Tops Revenue Estimates
Portfolio Pulse from
Pulmonx Corporation (LUNG) reported a Q4 loss of $0.33 per share, which was better than the Zacks Consensus Estimate of a $0.43 loss. This is an improvement from the $0.36 loss per share reported a year ago.
February 19, 2025 | 11:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Pulmonx Corporation reported a Q4 loss of $0.33 per share, better than the expected $0.43 loss, showing an improvement from last year's $0.36 loss.
The better-than-expected earnings report is likely to have a positive short-term impact on Pulmonx's stock price. Beating the consensus estimate and showing improvement from the previous year are positive indicators for investors.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100